General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Stockholders' Deficit

v2.4.0.8
Condensed Consolidated Statements of Stockholders' Deficit (USD $)
Total
Convertible Preferred Stock [Member]
Convertible Preferred Stock [Member]
Series A-2 [Member]
Convertible Preferred Stock [Member]
Series B [Member]
Common Stock [Member]
Common Stock [Member]
Series A-2 [Member]
Common Stock [Member]
Series B [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Series A-2 [Member]
Additional Paid-in Capital [Member]
Series B [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Series A-2 [Member]
Accumulated Deficit [Member]
Series B [Member]
Beginning balance at Dec. 31, 2011 $ (10,422,034) $ 8,199,909     $ 9,739     $ 670,514     $ (11,102,287)    
Beginning balance, shares at Dec. 31, 2011   4,820,549     9,738,580                
Issuance of convertible preferred stock in exchange for cash      8,476,074                       
Issuance of convertible preferred stock in exchange for cash, shares     4,011,135                     
Issuance of common stock upon exercise of options 31,716        156     31,560           
Issuance of common stock upon exercise of options, shares 156,624        156,624                
Common stock repurchased (812)        (8)     (804)           
Common stock repurchased, shares          (8,125)                
Vesting of early exercised options 13,233        33     13,200           
Stock-based compensation expense 333,466               333,466           
Net loss (15,041,958)                      (15,041,958)    
Ending balance at Dec. 31, 2012 (25,086,389) 16,675,983     9,920     1,047,936     (26,144,245)    
Ending balance, shares at Dec. 31, 2012   8,831,684     9,887,079                
Issuance of convertible preferred stock in exchange for cash        4,294,259                     
Issuance of convertible preferred stock in exchange for cash, shares       2,088,820                   
Issuance of Series B convertible preferred stock upon conversion of convertible debt and accrued interest 136,380 6,490,071                         
Issuance of Series B convertible preferred stock upon conversion of convertible debt and accrued interest, shares   3,090,524                      
Common stock warrants issued in connection with issuance of Series B convertible preferred stock    275                         
Common stock warrants issued in connection with issuance of Series B convertible preferred stock    (136,380)            136,380           
Issuance of common stock upon exercise of options 65,593        94     65,499           
Issuance of common stock upon exercise of options, shares 504,321        506,196                
Common stock repurchased (189)        (2)     (187)           
Common stock repurchased, shares          (1,875)                
Vesting of early exercised options 3,974        13     3,961           
Compensation expense for options issued a non-employee 4,679               4,679           
Stock-based compensation expense 390,618               390,618           
Net loss (11,887,374)                      (11,887,374)    
Ending balance at Dec. 31, 2013 $ (36,372,708) $ 27,324,208     $ 10,025     $ 1,648,886     $ (38,031,619)    
Ending balance, shares at Dec. 31, 2013   14,011,028     10,391,400